Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

書誌詳細
第一著者: Tabassum, Nadira
その他の著者: Yasmin, Hasina
フォーマット: 学位論文
言語:English
出版事項: Brac University 2024
主題:
オンライン・アクセス:http://hdl.handle.net/10361/22868
id 10361-22868
record_format dspace
spelling 10361-228682024-06-09T09:20:26Z Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study Tabassum, Nadira Yasmin, Hasina School of Pharmacy, Brac University Pharmacovigilance Alzheimer disease Dementia Rhabdomyolysis Alzheimer's disease Dementia This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from PDF version of thesis. Includes bibliographical references (pages 37-41). Alzheimer’s disease is a neurodegenerative disease. Using FDA Adverse Event Reporting System database, a pharmacovigilance study for gender specific rhabdomyolysis risk in memantine users was conducted between January 2016-June 2023. “R” statistical tool was used to calculate the reporting odds ratio (95%CI), which serves as a signal index. Memantine showed a signal, when the whole dataset is used as a comparator, but not when AChEIs are used. ROR,95% CI value for male memantine consumers 5.68 (2.12 - 15.19), for female 7.98 (2.55-24.70) while using whole dataset as comparator. Again, male patients value is 1.40 (0.46 - 4.26), whereas 2.53 (0.65 - 9.83) for females, using AChEIs as comparator. Females have a higher risk of developing rhabdomyolysis than males as the ROR value was higher for them in both comparisons. Thus, data shows memantine has a safer, more acceptable profile than AChEIs & can be considered in comparison to other options. Nadira Tabassum B. Pharmacy 2024-05-19T08:17:32Z 2024-05-19T08:17:32Z ©2023 2023-10 Thesis ID 19346012 http://hdl.handle.net/10361/22868 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 61 pages application/pdf Brac University
institution Brac University
collection Institutional Repository
language English
topic Pharmacovigilance
Alzheimer disease
Dementia
Rhabdomyolysis
Alzheimer's disease
Dementia
spellingShingle Pharmacovigilance
Alzheimer disease
Dementia
Rhabdomyolysis
Alzheimer's disease
Dementia
Tabassum, Nadira
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
description This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
author2 Yasmin, Hasina
author_facet Yasmin, Hasina
Tabassum, Nadira
format Thesis
author Tabassum, Nadira
author_sort Tabassum, Nadira
title Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
title_short Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
title_full Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
title_fullStr Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
title_full_unstemmed Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
title_sort gender-specific rhabdomyolysis risk in alzheimer’s disease patients receiving memantine: a pharmacovigilance study
publisher Brac University
publishDate 2024
url http://hdl.handle.net/10361/22868
work_keys_str_mv AT tabassumnadira genderspecificrhabdomyolysisriskinalzheimersdiseasepatientsreceivingmemantineapharmacovigilancestudy
_version_ 1814308170837786624